Higher testosterone/estradiol ratio linked to elevated risk for incident cardiovascular disease

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.ASHP: SVP, …